Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Myelodysplastic Syndromes 48Leukemia 35Lymphoma 24Leukemia, Lymphocytic, Chronic, B-Cell 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Lymphoma, Non-Hodgkin 21Hodgkin Disease 21Multiple Myeloma 18Hematologic Neoplasms 18Leukemia, Myelomonocytic, Chronic 11Leukemia, Biphenotypic, Acute 9Graft vs Host Disease 9Myeloproliferative Disorders 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Neoplasms, Plasma Cell 6Lymphoma, Follicular 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Accelerated Phase 4Hemoglobinuria, Paroxysmal 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Recurrence 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

blinatumomab 15Cyclophosphamide 15Cytarabine 14Azacitidine 11venetoclax 10fludarabine 10fludarabine phosphate 7Methotrexate 7Daunorubicin 7Rituximab 6Vincristine 5Mercaptopurine 5Whole-Body Irradiation 4Melphalan 4Idarubicin 4Etoposide 4Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Dexamethasone 3Cladribine 3Busulfan 3Asparaginase 3thymoglobulin 2pembrolizumab 2pegaspargase 2nilotinib 2midostaurin 2daratumumab 2Vindesine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × Stem Cell Transplantation × Other hematologic neoplasm × Clear all
NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡